Anti-BCMA/CD19 CAR T cell therapy in patients with refractory generalized myasthenia gravis: a single-arm, phase 1 trialYong Zhang, Ming Shi, Zhouao Zhang et al.|EClinicalMedicine|2025Cited by 12